AChR-seropositive myasthenia gravis in muscular dystrophy: diagnostic pitfalls and clinical management challenges-Reference-Cited by-同舟云学术

AChR-seropositive myasthenia gravis in muscular dystrophy: diagnostic pitfalls and clinical management challenges

Published:2024-07-05 Issue: Volume: Page:
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Avallone Anna Rosa,Di Stefano Vincenzo,Bevilacqua Liliana,Alonge Paolo,Lupica Antonino,Maccora Simona,Monastero Roberto,Amabile Sonia,Barone Paolo,Brighina Filippo,Vinciguerra Claudia

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10072-024-07675-6.pdf

Reference34 articles.

1. Brais B, Bouchard JP, Xie YG, Rochefort DL, Chrétien N, Tomé FM, Lafrenière RG, Rommens JM, Uyama E, Nohira O, Blumen S, Korczyn AD, Heutink P, Mathieu J, Duranceau A, Codère F, Fardeau M, Rouleau GA (1998) Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet. 18(2):164-7. https://doi.org/10.1038/ng0298-164. Erratum in: Nat Genet 1998;19(4):404. PMID: 9462747

2. Ricci G, Mele F, Govi M, Ruggiero L, Sera F, Vercelli L, Bettio C, Santoro L, Mongini T, Villa L, Moggio M, Filosto M, Scarlato M, Previtali SC, Tripodi SM, Pegoraro E, Telese R, Di Muzio A, Rodolico C, Bucci E, Antonini G, D’Angelo MG, Berardinelli A, Maggi L, Piras R, Maioli MA, Siciliano G, Tomelleri G, Angelini C, Tupler R (2020) Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis. Sci Rep 10(1):21648. https://doi.org/10.1038/s41598-020-78578-7PMID: 33303865; PMCID: PMC7730397

3. Ruggiero L, Mele F, Manganelli F, Bruzzese D, Ricci G, Vercelli L, Govi M, Vallarola A, Tripodi S, Villa L, Di Muzio A, Scarlato M, Bucci E, Antonini G, Maggi L, Rodolico C, Tomelleri G, Filosto M, Previtali S, Angelini C, Berardinelli A, Pegoraro E, Moggio M, Mongini T, Siciliano G, Santoro L, Tupler R (2020) Phenotypic variability among patients with D4Z4 reduced Allele Facioscapulohumeral muscular dystrophy. JAMA Netw Open 3(5):e204040. https://doi.org/10.1001/jamanetworkopen.2020.4040PMID: 32356886; PMCID: PMC7195625

4. Kleefeld F, Schoser B (2023) The current clinical perception of myotonic dystrophy type 2. Curr Opin Neurol. 36(5):474–478. doi: 10.1097/WCO.0000000000001186. Epub 2023 Jul 18. PMID: 37639480

5. Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM (2019) Myasthenia gravis. Nat Rev Dis Primers. 5(1):30. https://doi.org/10.1038/s41572-019-0079-y. PMID: 31048702